CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a ...

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered ...

CVS Caremark is putting Eli Lilly’s obesity drug Zepbound back on some commercial formularies starting Oct. 1, reversing a mid-2025 decision that had nudged many patients toward rival GLP-1 ...

CVS Caremark, one of the nation's largest pharmacy benefit managers, recently announced a new partnership with the discount drug service GoodRx, aiming to lower out-of-pocket prescription costs for ...